Cargando…
Comparison of Characteristics, Follow-up and Outcomes of Active Surveillance for Prostate Cancer According to Ethnicity in the GAP3 Global Consortium Database
BACKGROUND: Studies of active surveillance (AS) for prostate cancer (PCa) have focussed predominantly on Caucasian populations. Little is known about the experience of Asian men, while suitability for men of African descent has been questioned. OBJECTIVE: To compare baseline characteristics, follow-...
Autores principales: | Beckmann, Kerri, Santaolalla, Aida, Helleman, Jozien, Carroll, Peter, Ha Chung, Byung, Shiong Lee, Lui, Perry, Antoinette, Rubio-Briones, Jose, Sugimoto, Mikio, Trock, Bruce, Valdagni, Riccardo, Dasgupta, Prokar, Van Hemelrijck, Mieke, Elhage, Oussama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655390/ https://www.ncbi.nlm.nih.gov/pubmed/34934967 http://dx.doi.org/10.1016/j.euros.2021.09.012 |
Ejemplares similares
-
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative
por: Remmers, Sebastiaan, et al.
Publicado: (2022) -
Risk of progression following a negative biopsy in prostate cancer active surveillance
por: Beckmann, Kerri, et al.
Publicado: (2022) -
Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation’s Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium
por: Olivier, Jonathan, et al.
Publicado: (2022) -
Comparison of outcomes of different biopsy schedules among men on active surveillance for prostate cancer: An analysis of the G.A.P.3 global consortium database
por: Beckmann, Kerri R., et al.
Publicado: (2022) -
Correction to: Guy’s and St Thomas NHS Foundation active surveillance prostate cancer cohort: a characterisation of a prostate cancer active surveillance database
por: Shah, Salonee, et al.
Publicado: (2022)